B Lynne Parshall News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Oppenheimer Boosts Ionis Pharmaceuticals (NASDAQ:IONS) Price Target to $72 00

Ionis Pharmaceuticals (NASDAQ:IONS – Free Report) had its price target boosted by Oppenheimer from $65.00 to $72.00 in a report released on Wednesday, Benzinga reports. The brokerage currently has an outperform rating on the stock. A number of other research firms also recently weighed in on IONS. Royal Bank of Canada lifted their price target […]

New zealand generalNew zealandUnited statesB lynne parshallWilliam blairPiper sandlerRoyal bankPricet rowe associates incSecurities exchange commissionVanguard group incIonis pharmaceuticals stock downIonis pharmaceuticalsJpmorgan chase coT rowe price investment management incWellington management groupIonis pharmaceuticals inc

Ionis Pharmaceuticals, Inc (NASDAQ:IONS) Given Average Rating of Moderate Buy by Brokerages

Ionis Pharmaceuticals, Inc (NASDAQ:IONS) Given Average Rating of Moderate Buy by Brokerages
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesPiper sandlerWilliam blairEugene schneiderStifel nicolausB lynne parshallNews ratings for ionis pharmaceuticals dailySecurities exchange commissionHedge funds weigh in on ionis pharmaceuticalsIonis pharmaceuticalsIonis pharmaceuticals stockCalifornia public employees retirement systemAnalyst recommendations for ionis pharmaceuticalsCharles schwab investment management incIonis pharmaceuticals incIonis pharmaceuticals company profile

Ionis Pharmaceuticals (IONS) to Release Quarterly Earnings on Wednesday

Ionis Pharmaceuticals (IONS) to Release Quarterly Earnings on Wednesday
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesB lynne parshallAlmanack investment partnersIonis pharmaceuticals stock performanceGoldman sachs groupIonis pharmaceuticals incSecurities exchange commissionNews ratings for ionis pharmaceuticals dailyRoyal bankComerica bankQuilter plcHedge funds weigh in on ionis pharmaceuticalsMorgan stanleyIonis pharmaceuticalsEarnings history for ionis pharmaceuticalsGet free report

Ionis Pharmaceuticals (NASDAQ:IONS) Downgraded by StockNews com to Sell

Ionis Pharmaceuticals (NASDAQ:IONS) Downgraded by StockNews com to Sell
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesB lynne parshallWilliam blairNeedham companyIonis pharmaceuticalsIonis pharmaceuticals incSecurities exchange commissionIonis pharmaceuticals company profileAnalyst recommendations for ionis pharmaceuticalsInstitutional investors weigh in on ionis pharmaceuticalsNews ratings for ionis pharmaceuticals dailyJpmorgan chase coComerica bankIonis pharmaceuticals stock performanceQuilter plcPingora partners

Ionis Pharmaceuticals (NASDAQ:IONS) Downgraded by StockNews com to Sell

Ionis Pharmaceuticals (NASDAQ:IONS – Get Free Report) was downgraded by equities researchers at StockNews.com from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Friday. IONS has been the subject of a number of other reports. Needham & Company LLC reaffirmed a “buy” rating and set a […]

United statesWilliam blairPiper sandlerPatrickr oneilB lynne parshallStifel nicolausAnalyst recommendations for ionis pharmaceuticalsIonis pharmaceuticals stock performanceIonis pharmaceuticals incPingora partnersIonis pharmaceuticals company profileIonis pharmaceuticalsNews ratings for ionis pharmaceuticals dailyNeedham companyPeoples bankGet free report